Oxidative Damage and Schizophrenia: An Overview of the Evidence and Its Therapeutic Implications

ISSN： 1172-7047

Source： CNS Drugs, Vol.15, Iss.4, 2001-01, pp. : 287-310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications

By Harrison Paul

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 151-162

Springer Publishing Company

Access to resources Recommend Favorite

The Role of Phosphodiesterases in Schizophrenia: Therapeutic Implications

By Siuciak Judith A.

CNS Drugs, Vol. 22, Iss. 12, 2008-01 ,pp. : 983-993

Adis International

Access to resources Recommend Favorite

Depression and Heart Disease: Evidence of a Link, and its Therapeutic Implications

By Jiang W.

CNS Drugs, Vol. 16, Iss. 2, 2002-01 ,pp. : 111-127

Adis International

Access to resources Recommend Favorite

GABA B Receptors, Schizophrenia and Sleep Dysfunction: A Review of the Relationship and its Potential Clinical and Therapeutic Implications

By Kantrowitz Joshua Citrome Leslie Javitt Daniel

CNS Drugs, Vol. 23, Iss. 8, 2009-08 ,pp. : 681-691

Adis International

Access to resources Recommend Favorite

Abnormal mesolimbic dopamine function following neonatal hippocampal damage: implications for schizophrenia

By Lipska B.K. Lillrank S.M. Wood G.K. Weinberger D.R.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 230-230

Elsevier

Access to resources Recommend Favorite